BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders: some common and contrasting features

Leukemia. 2008 Nov;22(11):1975-89. doi: 10.1038/leu.2008.231.

Authors

N C P Cross, G Q Daley, A R Green, T P Hughes, C Jamieson, P Manley, T Mughal, D Perrotti, J Radich, R Skoda, S Soverini, W Vainchenker, S Verstovsek, J-L Villeval, J M Goldman

PMID: 19002192
DOI: 10.1038/leu.2008.231

No abstract available

Publication types

Editorial

MeSH terms

Chronic Disease
Clinical Trials as Topic
Fusion Proteins, bcr-abl / genetics*
Genomic Instability
Humans
Janus Kinase 2 / genetics
Janus Kinase 2 / metabolism
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
Myeloproliferative Disorders / genetics*
Myeloproliferative Disorders / pathology
Myeloproliferative Disorders / therapy

Substances

Fusion Proteins, bcr-abl
JAK2 protein, human
Janus Kinase 2